Published in J Biol Chem on February 10, 1974
Activation of human platelet phospholipase C by ionophore A23187 is totally dependent upon cyclo-oxygenase products and ADP. Biochem J (1984) 1.59
Immunoinhibition of ristocetin-induced platelet aggregation. J Clin Invest (1977) 1.26
Uptake of 5-hydroxytryptamine by rat blood platelets and its inhibition by adenosine 5'-diphosphate. Br J Pharmacol (1976) 1.16
Binding of collagen alpha1 chains to human platelets. J Clin Invest (1977) 0.96
Binding of adenosine diphosphate to intact human platelets. J Physiol (1975) 0.83
Increased fluidity of human platelet membranes during complement-mediated immune platelet injury. J Clin Invest (1978) 0.79
Isolation of human platelet plasma membranes with polylysine beads. J Cell Biol (1979) 0.78
Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest (1973) 31.28
Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest (1973) 10.18
A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes. J Clin Invest (1989) 3.71
Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci U S A (1997) 3.30
Isolation of the thrombospondin membrane receptor. J Clin Invest (1987) 2.87
Synthesis of von Willebrand factor by cultured human endothelial cells. Proc Natl Acad Sci U S A (1974) 2.83
A clinical study of the lupus anticoagulant. Blood (1976) 2.81
Respiratory disease rates and pulmonary function in children associated with NO2 exposure. Am Rev Respir Dis (1980) 2.63
Contractile proteins of endothelial cells, platelets and smooth muscle. Am J Pathol (1973) 2.36
Fluorescent virions: dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells. Hum Gene Ther (1998) 2.27
Complex formation of platelet thrombospondin with fibrinogen. J Clin Invest (1982) 2.05
Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen. J Clin Invest (1982) 2.04
Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody. N Engl J Med (1986) 2.01
Thrombospondin is the endogenous lectin of human platelets. Nature (1982) 1.98
Increased vascular permeability produced by human platelet granule cationic extract. J Clin Invest (1970) 1.98
Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices. Ann Thorac Surg (1995) 1.96
Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood (1995) 1.94
Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion. Blood (1994) 1.90
Binding of plasminogen to cultured human endothelial cells. J Biol Chem (1986) 1.87
Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature (1989) 1.85
Cancer and clotting--Trousseau's warning. N Engl J Med (1992) 1.78
Blockade of clearance of immune complexes by an anti-Fc gamma receptor monoclonal antibody. J Exp Med (1986) 1.75
Iodination of the human platelet membrane. Studies of the major surface glycoprotein. J Biol Chem (1973) 1.72
Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor. J Exp Med (1986) 1.68
Rabbit platelet bactericidal protein. J Exp Med (1971) 1.63
Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors. J Virol (1999) 1.59
Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus. J Clin Invest (1999) 1.56
Subunit structure of factor VIII antigen synthesized by cultured human endothelial cells. J Clin Invest (1975) 1.56
Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion. J Clin Invest (1987) 1.53
Drug purpura. Semin Hematol (1965) 1.53
Complex formation of platelet thrombospondin with plasminogen. Modulation of activation by tissue activator. J Clin Invest (1984) 1.52
Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells. J Exp Med (1987) 1.50
Subcellular platelet factor VIII antigen and von Willebrand factor. J Exp Med (1975) 1.43
Complex formation of platelet thrombospondin with histidine-rich glycoprotein. J Clin Invest (1984) 1.43
Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation. J Exp Med (1998) 1.43
Binding of plasminogen to extracellular matrix. J Biol Chem (1986) 1.38
Isolation, purification, and partial characterization of platelet membrane glycoproteins IIb and IIIa. J Biol Chem (1981) 1.37
Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis. J Biol Chem (1991) 1.36
Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding. Biochem Biophys Res Commun (1992) 1.32
Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion. J Clin Invest (1989) 1.32
Macrophage plasma membranes. I. Isolation and studies on protein components. J Exp Med (1971) 1.32
Human megakaryocytes. I. Characterization of the membrane and cytoplasmic components of isolated marrow megakaryocytes. J Exp Med (1979) 1.31
Human brain glial cells synthesize thrombospondin. Proc Natl Acad Sci U S A (1986) 1.29
Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts. Blood (1981) 1.28
Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells. J Clin Invest (1987) 1.28
Immunoinhibition of ristocetin-induced platelet aggregation. J Clin Invest (1977) 1.26
Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein. J Clin Invest (1985) 1.24
Human platelet activation by C3a and C3a des-arg. J Exp Med (1983) 1.22
Characterization of human platelet vascular permeability-enhancing activity. J Clin Invest (1972) 1.20
Immunologic studies of proteins associated with subcellular fractions of normal human platelets. J Lab Clin Med (1967) 1.20
Thrombospondin: a versatile multifunctional glycoprotein. Arteriosclerosis (1986) 1.19
Increased skin permeability in preterm infants. J Pediatr (1971) 1.18
Structural analysis of human platelet membrane glycoprotein I complex. Proc Natl Acad Sci U S A (1979) 1.18
Studies on human platelet protease activity. J Clin Invest (1969) 1.17
Binding of tissue plasminogen activator to cultured human endothelial cells. J Clin Invest (1987) 1.15
Human megakaryocytes. II. Expression of platelet proteins in early marrow megakaryocytes. J Exp Med (1981) 1.14
Thrombin-induced platelet membrane glycoprotein IIb and IIIa complex formation. An electron microscope study. J Exp Med (1981) 1.13
Human complement in thrombin-mediated platelet function: uptake of the C5b-9 complex. J Exp Med (1979) 1.13
Activation of immobilized plasminogen by tissue activator. Multimolecular complex formation. J Biol Chem (1985) 1.12
Effect of intensity of physical activity on body fatness and fat distribution. Am J Clin Nutr (1990) 1.12
Cellular attachment to thrombospondin. Cooperative interactions between receptor systems. J Biol Chem (1991) 1.12
Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in human saliva. J Exp Med (1998) 1.11
Longitudinal height velocity standards for U.S. adolescents. Stat Med (1993) 1.10
Macrophage plasma membrane. II. Studies on synthesis and turnover of protein constituents. J Exp Med (1971) 1.08
Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1. J Clin Invest (2001) 1.08
Thrombocytopenia due to digitoxin. Demonstration of antibody and mechanisms of action. Am J Med (1966) 1.08
Transendothelial migration of CD34+ and mature hematopoietic cells: an in vitro study using a human bone marrow endothelial cell line. Blood (1997) 1.07
Studies on the proteins of human platelet membranes. J Biol Chem (1972) 1.06
Ultrastructure of thrombosthenin, the contractile protein of human blood platelets. Science (1967) 1.05
Human platelet membrane protein. Biochemistry (1970) 1.05
Ultrastructural lesions on the surface of platelets associated with either blood coagulation or with antibody-mediated immune injury. J Exp Med (1975) 1.04
The platelet as an inflammatory cell. Ann N Y Acad Sci (1972) 1.04
Histidine-rich glycoprotein is present in human platelets and is released following thrombin stimulation. Blood (1983) 1.04
Interaction of platelet membrane receptors with von Willebrand factor, ristocetin, and the Fc region of immunoglobulin G. J Clin Invest (1978) 1.03
Platelet membrane topography: colocalization of thrombospondin and fibrinogen with the glycoprotein IIb-IIIa complex. Blood (1985) 1.03
Daily diaries of respiratory symptoms and air pollution: methodological issues and results. Environ Health Perspect (1991) 1.01
Matrix plasminogen activator inhibitor. Modulation of the extracellular proteolytic environment. J Biol Chem (1988) 1.00
Effector cell protease receptor-1 is a vascular receptor for coagulation factor Xa. J Biol Chem (1996) 0.99
Thrombospondin: phenomenology to function. Prog Hemost Thromb (1989) 0.99
BMEC-1: a human bone marrow microvascular endothelial cell line with primary cell characteristics. Microvasc Res (1996) 0.98
Structural analysis of factor VIII antigen in von Willebrand disease. Proc Natl Acad Sci U S A (1980) 0.98
Human complement in the arachidonic acid transformation pathway in platelets. J Exp Med (1981) 0.97
Reed-Sternberg cells in Hodgkin's disease contain fibronectin. Blood (1981) 0.96
The treatment of congenital knee dislocation. A review of nineteen knees. Clin Orthop Relat Res (1987) 0.96
Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract. Hum Gene Ther (1997) 0.95
Blindness without direct injury to the globe: a complication of facial fractures. Plast Reconstr Surg (1976) 0.94
Inhibition of fibrin monomer polymerization by lambda myeloma globulins. Blood (1972) 0.93